This idea was pioneered by Bao and collaborators in glioblastoma multiform (GBM) where cells expressing CD133 (Prominin-1), a marker for both neural stem cells and brain cancer stem cells, preferentially activate the DNA damage checkpoint in response to radiation. This evidence concerns the gene PROM1 and glioblastoma.